Literature DB >> 22946748

Focal seizures with affective symptoms are a major feature of PCDH19 gene-related epilepsy.

Carla Marini1, Francesca Darra, Nicola Specchio, Davide Mei, Alessandra Terracciano, Lucio Parmeggiani, Annarita Ferrari, Federico Sicca, Massimo Mastrangelo, Luigina Spaccini, Maria Lucia Canopoli, Elisabetta Cesaroni, Nelia Zamponi, Lorella Caffi, Paolo Ricciardelli, Salvatore Grosso, Tiziana Pisano, Maria Paola Canevini, Tiziana Granata, Patrizia Accorsi, Domenica Battaglia, Raffaella Cusmai, Federico Vigevano, Bernardo Dalla Bernardina, Renzo Guerrini.   

Abstract

PURPOSE: Mutations of the protocadherin19 gene (PCDH19) cause a female-related epilepsy of variable severity, with or without mental retardation and autistic features. Despite the increasing number of patients and mutations reported, the epilepsy phenotype associated with PCDH19 mutations is still unclear. We analyzed seizure semiology through ictal video-electroencephalography (EEG) recordings in a large series of patients.
METHODS: We studied 35 patients with PCDH19 gene-related epilepsy and analyzed clinical history and ictal video-EEG recordings obtained in 34 of them. KEY
FINDINGS: Clusters of focal febrile and afebrile seizures had occurred in 34 patients, at a mean age of 10 months. The predominant and more consistent ictal sign was fearful screaming, occurring in 24 patients (70.5%); it was present since epilepsy onset in 12 and appeared later on, during the course in the remaining 12 patients. In infancy, fearful screaming mainly appeared within the context of seizures with prominent hypomotor semiology, whereas during follow-up it was associated with prominent early motor manifestations. In 16 patients, seizures were video-EEG recorded both at onset and during follow-up: in five patients (31%) seizure semiology remained identical, in 7 (44%) semiology varied and in four patients it was unclear whether ictal semiology changed with age. Three patients (9%) had both focal and generalized seizures, the latter consisting of absences and myoclonus. Ictal EEG during focal seizures showed a prominent involvement of the frontotemporal regions (22 patients). About 45% of patients had an alternating EEG pattern, with the ictal discharge migrating from one hemisphere to the contralateral during the same ictal event. Status epilepticus occurred in 30% of patients. Cognitive impairment occurred in 70%, ranging from mild (42%) to moderate (54%) and severe (4%); autistic features occurred in 28.5%. Direct sequencing detected 33 different heterozygous candidate mutations, 8 of which were novel. Mutations were missense substitutions (48.5%), premature termination (10 frameshift, 4 nonsense, and 2 splice-site mutations; 48.5%), and one in-frame deletion. Thirty candidate mutations (91%) were de novo. No specific genotype-phenotype correlation could be established, as missense and truncating mutations were associated with phenotypes of comparable severity. SIGNIFICANCE: Most patients with PCDH19 mutations exhibit a distinctive electroclinical pattern of focal seizures with affective symptoms, suggesting an epileptogenic dysfunction involving the frontotemporal limbic system. Awareness of this distinctive phenotype will likely enhance recognition of this disorder. Wiley Periodicals, Inc.
© 2012 International League Against Epilepsy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22946748     DOI: 10.1111/j.1528-1167.2012.03649.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  18 in total

1.  PCDH19-related epilepsy is associated with a broad neurodevelopmental spectrum.

Authors:  Lacey Smith; Nilika Singhal; Christelle M El Achkar; Gessica Truglio; Beth Rosen Sheidley; Joseph Sullivan; Annapurna Poduri
Journal:  Epilepsia       Date:  2018-01-28       Impact factor: 5.864

2.  Clinical and genetic aspects of PCDH19-related epilepsy syndromes and the possible role of PCDH19 mutations in males with autism spectrum disorders.

Authors:  J J T van Harssel; S Weckhuysen; M J A van Kempen; K Hardies; N E Verbeek; C G F de Kovel; W B Gunning; E van Daalen; M V de Jonge; A C Jansen; R J Vermeulen; W F M Arts; H Verhelst; A Fogarasi; J F de Rijk-van Andel; A Kelemen; D Lindhout; P De Jonghe; B P C Koeleman; A Suls; E H Brilstra
Journal:  Neurogenetics       Date:  2013-01-20       Impact factor: 2.660

Review 3.  The hidden genetics of epilepsy-a clinically important new paradigm.

Authors:  Rhys H Thomas; Samuel F Berkovic
Journal:  Nat Rev Neurol       Date:  2014-04-15       Impact factor: 42.937

Review 4.  Epilepsy and mental retardation restricted to females: X-linked epileptic infantile encephalopathy of unusual inheritance.

Authors:  Kinga Duszyc; Iwona Terczynska; Dorota Hoffman-Zacharska
Journal:  J Appl Genet       Date:  2014-09-10       Impact factor: 3.240

Review 5.  Genetic epilepsy syndromes without structural brain abnormalities: clinical features and experimental models.

Authors:  Renzo Guerrini; Carla Marini; Massimo Mantegazza
Journal:  Neurotherapeutics       Date:  2014-04       Impact factor: 7.620

6.  Structural determinants of adhesion by Protocadherin-19 and implications for its role in epilepsy.

Authors:  Sharon R Cooper; James D Jontes; Marcos Sotomayor
Journal:  Elife       Date:  2016-10-26       Impact factor: 8.140

7.  Male patients affected by mosaic PCDH19 mutations: five new cases.

Authors:  I M de Lange; P Rump; R F Neuteboom; P B Augustijn; K Hodges; A I Kistemaker; O F Brouwer; G M S Mancini; H A Newman; Y J Vos; K L Helbig; C Peeters-Scholte; M Kriek; N V Knoers; D Lindhout; B P C Koeleman; M J A van Kempen; E H Brilstra
Journal:  Neurogenetics       Date:  2017-07-01       Impact factor: 2.660

8.  Characterizing PCDH19 in human induced pluripotent stem cells (iPSCs) and iPSC-derived developing neurons: emerging role of a protein involved in controlling polarity during neurogenesis.

Authors:  Claudia Compagnucci; Stefania Petrini; Norimichi Higuraschi; Marina Trivisano; Nicola Specchio; Shinichi Hirose; Enrico Bertini; Alessandra Terracciano
Journal:  Oncotarget       Date:  2015-09-29

9.  Molecular diagnosis of patients with epilepsy and developmental delay using a customized panel of epilepsy genes.

Authors:  Laura Ortega-Moreno; Beatriz G Giráldez; Victor Soto-Insuga; Rebeca Losada-Del Pozo; María Rodrigo-Moreno; Cristina Alarcón-Morcillo; Gema Sánchez-Martín; Esther Díaz-Gómez; Rosa Guerrero-López; José M Serratosa
Journal:  PLoS One       Date:  2017-11-30       Impact factor: 3.240

10.  Clinical Application of Epilepsy Genetics in Africa: Is Now the Time?

Authors:  Alina I Esterhuizen; Gemma L Carvill; Rajkumar S Ramesar; Symon M Kariuki; Charles R Newton; Annapurna Poduri; Jo M Wilmshurst
Journal:  Front Neurol       Date:  2018-05-02       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.